首页> 外国专利> Crystalline Polymorph II (2S, 3S, 5S) - 5 - N - N - N - methyl - N - (2 - isopropyl - 4-thiazolyl) methyl amino carbonyl - L - valinil amino - 2 - (5 - N - (Methoxycarbonyl 2-amino-4-thiazolyl) amino - 1,6 - Diphenyl - 3 - hidroxihexano (ritonavir); Preparation procedure; Pharmaceutical composition useful for the inhibition of HIV Protease.

Crystalline Polymorph II (2S, 3S, 5S) - 5 - N - N - N - methyl - N - (2 - isopropyl - 4-thiazolyl) methyl amino carbonyl - L - valinil amino - 2 - (5 - N - (Methoxycarbonyl 2-amino-4-thiazolyl) amino - 1,6 - Diphenyl - 3 - hidroxihexano (ritonavir); Preparation procedure; Pharmaceutical composition useful for the inhibition of HIV Protease.

机译:结晶多晶型物II(2S,3S,5S)-5-[N-[N-[N-甲基-N-[(2-异丙基-4-噻唑基)甲基]氨基]羰基] -L-缬氨酸]氨基]- 2-(5- [N-(N-(甲氧羰基2-氨基-4-噻唑基))氨基] -1,6-二苯基-3-hidroxihexano(利托那韦);制备方法;可用于抑制HIV蛋白酶的药物组合物。

摘要

The present invention relates to substantially pure amorphous ritonavir and a process for the preparation thereof. The invention also relates to a process for the praparation of the substantially pure ritonavir crystalline polymorph Form I. IMAGE
机译:本发明涉及基本上纯的无定形利托那韦及其制备方法。本发明还涉及用于制备基本纯的利托那韦晶体多晶型物形式I的制备方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号